Global Glucose Monitoring Market Report: 2012 Edition

The worldwide market for blood glucose monitoring is mainly dependent on the number of diabetes patients in the world which is growing significantly and is expected to grow even further in the near future. As a result, the worldwide market for glucose monitoring devices should also grow. There is no cure for diabetes and it can only be controlled. In order to control it, blood glucose monitoring is mandatory.

Diabetes can be of 2 types i.e. type I and type II. Type II diabetes is so far more prevalent compared to type I. The type I diabetes can be monitored with the help of regular glucose monitoring devices and self monitoring blood glucose monitoring devices. Regular glucose monitoring is done with the help of standard hand prick glucose monitors. This segment contributes the major share of total sales of blood glucose monitoring industry. The blood glucose test strips which are required for glucose tests are disposable which means there is a steady growth opportunity in this market.

Continuous glucose monitoring is mainly required for type I diabetes patients or patients with very high blood glucose level. A type I diabetes is less prevalent; the market for CGM (Continuous glucose monitoring) devices is smaller compared to Regular glucose monitoring market. CGM is a costlier procedure and is not covered automatically by medical insurances which also affect the sales of this particular segment. CGM is an invasive procedure and operation is required to place the sensor in the patient’s body. As soon as the reimbursement of CGM improves, the perfomance of the market improve.

The global aging population, obese population, worldwide health expenditure and awareness about diabetes are the factors which are fuelling the growth of the glucose monitoring industry. The unwillingness of patients in frequent glucose test and increased competition in the developed market are the major challenges to the growth.

ABOUT THIS REPORT

The report provides an analysis of the glucose monitoring market. It also discusses the major trends, growth drivers and challenges in the market. The regular glucose monitoring market is mainly controlled by four major players namely Roche, J&J-Lifescan, Bayer and Abbott whereas the CGM market is controlled by Medtronic and Dexcom.

By combining SPSS Inc.’s data integration and analysis capabilities with relevant findings, the future growth of the global glucose monitoring devices market has been predicted. Various significant variables that have an impact on this industry and created regression models with SPSS Base have been used to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests. SHOW LESS READ MORE >

1. Glucose Monitoring

1.1 An Introduction

2. Glucose Monitoring - Market Size

Global Market Value
SMBG Market Value
SMBG Market by Region

3. Glucose Monitoring Market by Segments

3.1 Regular Glucose Monitoring Market
3.2 Continuous Glucose Monitoring Market

4. Key Trends

4.1 Growing Number of Global Diabetic Patients
4.2 Prevalence of Diabetes in Aging Population
4.3 Diabetes Prevalence: Men Vs Women
4.4 Shifted Focus towards CGM from Hand-prick Glucose Meters

5. Market Drivers

5.1 Rising Ageing Population
5.2 Increasing Urbanization
5.3 Rising Obese Population
5.4 Awareness about Blood Glucose Monitoring

6. Challenges

6.1 Increased Competition
6.2 Unwillingness of Diabetes Patients
6.3 Non-invasive Blood Glucose Monitoring

7. Significant Developments

7.1 CGM in Interstitial Adipose Tissue, Cerebral Cortex & Muscle
7.2 Minimally Invasive Blood Glucose Monitoring
7.3 Needle Sensor System

8. Competitive Landscape

Competitive Overview
Market Share

9. Company Profiles

9.1 Johnson & Johnson

Business Description
Key Financials
Business Strategies
Growth through Strategic Acquisitions
New Product Introductions

9.2 Abbott Lab

Business Description
Key Financials
Business Strategies
Strengthening Global Position
Leadership across Product Portfolio
Late-Stage Pharmaceutical Pipeline

9.3 Roche

Business Description
Key Financials
Business Strategies
Delivering Personalized Healthcare
Creating Sustainable Value
Fostering Innovation and Empowering People

9.4 Bayer AG

Business Description
Key Financials
Business Strategies
Diversification Strategy
Advancing Leadership Skills

10. Market Outlook

10.1 Market Forecast
10.2 Forecast Methodology

10.2.1 Dependent and Independent Variables
10.2.2 Correlation Analysis
10.2.3 Regression Analysis

List of Charts

Worldwide Market Size of Diabetes Devices, 2005-2010
Diabetes Equipment Market Volume of Emerging Markets, 2009-2010
Worldwide Market Size of Glucose Monitoring Devices, 2005-2010
Worldwide Market Size of Self Monitoring Blood Glucose and Strip Market, 2008-2010
Outlook of the US Blood Glucose Monitor Market, 2008-2015
Worldwide Market Size of Regular Glucose Monitoring Market, 2005-2010
Worldwide Market Size of Continuous Glucose Monitoring Market, 2005-2010
Current Status and Outlook for Global Diabetic Patients, 2010-2030
Global Prevalence Rate of Diabetes by Age Group, 2010
Prevalence Rate of Diabetes, 1998-2009
CGM Market Outlook, 2010-2016
Growth of Global Aging Population, 2005-2012E
Increasing Urban Population, 2005-2012E
Growth in Worldwide Obese Population, 2004-2012F
Diabetes Device Sales of Leading Companies, 2005-2010
Market Share of Top 4 Companies in SMBG Device Market, 2010
Market Share of Top 2 Companies in CGM Market, 2010
Average Price of Blood Glucose Test Strips, 2010
J&J’s Major Medical Devices and Diagnostics Franchise Sales, 2010
J&J’s Total and Medical Devices & Diagnostics segment Sales, 2008-2010
Abott - Share of Sales by Segments, 2010
Total Sales of Abbott, 2007-2010
Roche - Share of Sales by Segments, 2011
Total Sales of Roche, 2008-2011
Bayer - Share of Sales by Segments, 2011
Total Sales of Bayer, 2008-2011
Global Diabetic Population, 2010A-2015E

List of Tables

Type I and Type II Diabetes Market in the US, 2008-2010
SMBG Market by Geographic Segment, 2008-2010
US Market for ICU Continuous Glucose Monitoring, 2010
US CGM Device Comparisons
Dependent & Independent Variables (2005– 2010)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

Johnson & Johnson
Abbott Lab
Roche
Bayer AG